Goldman Sachs has maintained a Sell rating on Laurus Labs, while raising the target price to ₹675. The revised target implies a downside of approximately 20% from the current market price of ₹839.90.
While the company did not offer a quantitative revenue guidance for FY26, it stated that it has laid strong foundations for growth in FY26 and beyond. Laurus also indicated that it expects margins to improve in the current financial year.
Despite this positive commentary, Goldman Sachs remains cautious due to limited topline visibility and retains its bearish stance on the stock.
Disclaimer: This article is based on Goldman Sachs’ brokerage report and does not constitute investment advice. Please consult a certified financial advisor before making any investment decisions.
